We detected tumor infiltrating mDC (CD11c+ CD45+ I-Ab+, Fig. 1Ci) and MΦ (CD11b+ CD45+ I-Ab+, Fig. 1Cii) that represented 3.5% and 19% of the total number of CD45+ immune cells present in the tumor respectively. This evidence concerns the gene PTPRC and neoplasm.